Literature DB >> 26770503

Effect of progesterone intervention on the dynamic changes of AQP-4 in hypoxic-ischaemic brain damage.

Xiaojuan Li1, Ruiying Bai1, Junhe Zhang2, Xiaoyin Wang2.   

Abstract

To observe the effect of progesterone (PROG) on blood-brain barrier (BBB) permeability, brain tissue water content and dynamic changes of aquaporin-4 (AQP-4) in neonatal rats with hypoxic-ischaemic brain damage (HIBD). 72 neonatal Wistar rats, aged 7 days old, were randomly divided into control, hypoxic-ischaemic (6, 24 and 72 h, and 7 d subgroups) and drug groups (6, 24 and 72 h, and 7 d subgroups). The HIBD animal model was established. BBB was detected via an Evans blue tracer. Brain water content was determined by the dry/wet method. The AQP-4 expression in the cerebral cortex was observed through immunohistochemistry and Western blot. BBB permeability in the cerebral cortex of the neonatal rats, brain water content and AQP-4 expression in the hypoxia-ischaemia group were significantly higher than those of the control group after hypoxia for 6 h (P < 0.05), continued to rise within 24 h and then reached the peak at 72 h. BBB permeability in the cerebral cortex of the neonatal rats, brain water content and AQP-4 expression in the drug group were significantly lower than those of the hypoxia-ischaemia group after hypoxia for 6, 24 and 72 h (P < 0.05). Moreover, BBB permeability and BBB expression were positively correlated with the AQP-4 expression. In conclusion, PROG protects the brain of HIBD neonatal rats by alleviating the damage of BBB and cerebral oedema. The protective effect of PROG may be related to the down-regulation of AQP-4 expression in the cerebral cortex of neonatal rats.

Entities:  

Keywords:  Progesterone; aquaporin; blood-brain barrier; cerebral oedema; hypoxia-ischaemia

Year:  2015        PMID: 26770503      PMCID: PMC4694403     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  21 in total

1.  Effect of sex steroid hormones on brain edema, intracranial pressure, and neurologic outcomes after traumatic brain injury.

Authors:  Nader Shahrokhi; Mohammad Khaksari; Zahra Soltani; Mehdi Mahmoodi; Nouzar Nakhaee
Journal:  Can J Physiol Pharmacol       Date:  2010-04       Impact factor: 2.273

2.  The Akt/GSK-3β pathway mediates flurbiprofen-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rats.

Authors:  Baozhu Sun; Lin Chen; Xinbing Wei; Yanxiao Xiang; Xiaoqian Liu; Xiumei Zhang
Journal:  Biochem Biophys Res Commun       Date:  2011-05-23       Impact factor: 3.575

3.  Time- and dose-dependent neuroprotective effects of sex steroid hormones on inflammatory cytokines after a traumatic brain injury.

Authors:  Ali Reza Sarkaki; Mohammad Khaksari Haddad; Zahra Soltani; Nader Shahrokhi; Mehdi Mahmoodi
Journal:  J Neurotrauma       Date:  2012-11-16       Impact factor: 5.269

4.  Glycogen synthase kinase-3 inhibition reduces ischemic cerebral damage, restores impaired mitochondrial biogenesis and prevents ROS production.

Authors:  Alessandra Valerio; Paola Bertolotti; Andrea Delbarba; Carlo Perego; Marta Dossena; Maurizio Ragni; PierFranco Spano; Michele O Carruba; Maria Grazia De Simoni; Enzo Nisoli
Journal:  J Neurochem       Date:  2011-01-28       Impact factor: 5.372

5.  Progesterone and allopregnanolone exacerbate hypoxic-ischemic brain injury in immature rats.

Authors:  Masahiro Tsuji; Akihiko Taguchi; Makiko Ohshima; Yukiko Kasahara; Tomoaki Ikeda
Journal:  Exp Neurol       Date:  2011-10-14       Impact factor: 5.330

6.  Neuronal cell death in neonatal hypoxia-ischemia.

Authors:  Frances J Northington; Raul Chavez-Valdez; Lee J Martin
Journal:  Ann Neurol       Date:  2011-05       Impact factor: 10.422

7.  Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats.

Authors:  Yong-Man Zhu; Can-Can Wang; Long Chen; Ling-Bo Qian; Lei-Lei Ma; Jing Yu; Man-Hua Zhu; Chuan-Yun Wen; Li-Na Yu; Min Yan
Journal:  Brain Res       Date:  2012-12-05       Impact factor: 3.252

8.  Hemin‑mediated neuroglobin induction exerts neuroprotection following ischemic brain injury through PI3K/Akt signaling.

Authors:  Bei Zhang; Xiuping Ji; Shijun Zhang; Huiyun Ren; Minjuan Wang; Changjiang Guo; Yajun Li
Journal:  Mol Med Rep       Date:  2013-06-13       Impact factor: 2.952

9.  Apelin-36, a potent peptide, protects against ischemic brain injury by activating the PI3K/Akt pathway.

Authors:  Qin Gu; Lijing Zhai; Xing Feng; Jing Chen; Zhigang Miao; Liyan Ren; Xuanchen Qian; Jian Yu; Yan Li; Xingshun Xu; Chun-Feng Liu
Journal:  Neurochem Int       Date:  2013-09-29       Impact factor: 3.921

10.  Progesterone attenuates cerebral edema in neonatal rats with hypoxic-ischemic brain damage by inhibiting the expression of matrix metalloproteinase-9 and aquaporin-4.

Authors:  Xiaoyin Wang; Junhe Zhang; Yuxin Yang; Weihua Dong; Fang Wang; Li Wang; Xiaojuan Li
Journal:  Exp Ther Med       Date:  2013-05-15       Impact factor: 2.447

View more
  3 in total

Review 1.  Blood-brain barrier dysfunction and recovery after ischemic stroke.

Authors:  Xiaoyan Jiang; Anuska V Andjelkovic; Ling Zhu; Tuo Yang; Michael V L Bennett; Jun Chen; Richard F Keep; Yejie Shi
Journal:  Prog Neurobiol       Date:  2017-10-05       Impact factor: 11.685

Review 2.  Research into the Physiology of Cerebrospinal Fluid Reaches a New Horizon: Intimate Exchange between Cerebrospinal Fluid and Interstitial Fluid May Contribute to Maintenance of Homeostasis in the Central Nervous System.

Authors:  Mitsunori Matsumae; Osamu Sato; Akihiro Hirayama; Naokazu Hayashi; Ken Takizawa; Hideki Atsumi; Takatoshi Sorimachi
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-05-27       Impact factor: 1.742

3.  Association of Genetic Variation at AQP4 Locus with Vascular Depression.

Authors:  Anna L Westermair; Matthias Munz; Anja Schaich; Stefan Nitsche; Bastian Willenborg; Loreto M Muñoz Venegas; Christina Willenborg; Heribert Schunkert; Ulrich Schweiger; Jeanette Erdmann
Journal:  Biomolecules       Date:  2018-12-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.